Edelweiss Mutual Fund
High-growth potential mutual funds investing in top Indian companies.
Edelweiss Liquid Fund Regular Plan Growth Option
6.90% 3Y CAGR
Income over short term. Investments in money market and debt securities.
Edelweiss Small Cap Fund Regular Plan Growth
17.33% 3Y CAGR
Long-term capital appreciation. Investments predominantly in equity and equity related securities of small cap companies.
Edelweiss Overnight Fund Regular Plan Growth
6.08% 3Y CAGR
To generate short term optimal returns in line with overnight rates and high liquidity. To invest in money market and debt instruments with maturity of 1 day.
Bharat Bond Fof April 2030 Regular Plan Growth Option
7.54% 3Y CAGR
Income over the Target Maturity period. An open ended Target Maturity fund of funds scheme with the primary objective to generate returns by investing in units of BHARAT Bond ETF - April 2030
Edelweiss Us Technology Equity Fund Of Fund Regular Plan Growth
29.63% 3Y CAGR
Long Term Capital Growth. Investments predominantly in JPMorgan Funds - US Technology Fund, an equity oriented fund which invests primarily in US technology companies with strong fundamentals.
Bharat Bond Fof April 2025 Regular Plan Growth Option
Income over the Target Maturity period. An open ended Target Maturity fund of funds scheme with the primary objective to generate returns by investing in units of BHARAT Bond ETF - April 2025.
Bharat Bond Fof April 2031 Regular Plan Growth Option
7.44% 3Y CAGR
Income over the Target Maturity period. An open ended Target Maturity fund of funds scheme with the primary objective to generate returns by investing in units of BHARAT Bond ETF - April 2031
Edelweiss Msci India Domestic World Healthcare 45 Index Fund Regular Plan Growth
19.98% 3Y CAGR
Long Term Capital appreciation. Passive investment in equity and equity related securities replicating the composition of MSCI India Domestic & World Healthcare 45 Index, subject to tracking error.
Edelweiss Recently Listed Ipo Fund Regular Plan Growth
18.72% 3Y CAGR
Long-term capital growth. Investment in equity and equity-related securities recently listed 100 companies or upcoming Initial Public Offer (IPOs).
Edelweiss Nifty Psu Bond Plus Sdl Apr 2027 50 50 Index Fund Regular Plan Growth
7.17% 3Y CAGR
Income over long term. An open-ended Target Maturity Index Fund that seeks to track Nifty PSU Bond plus SDL April 2027 50:50 Index.
Edelweiss Nifty 50 Index Fund Regular Plan Growth
8.06% 3Y CAGR
Long term capital appreciation. Passive investment in equity and equity related securities replicating the composition of Nifty 50 Index, subject to tracking errors.
Edelweiss Nifty 100 Quality 30 Index Fund Regular Plan Growth
8.16% 3Y CAGR
Long term capital appreciation. Investment in securities covered by Nifty 100 Quality 30 Index.
Edelweiss Nifty Large Midcap 250 Index Fund Regular Plan Growth
14.16% 3Y CAGR
Long Term Capital appreciation. Passive Investment in equity and equity related securities replicating the composition of Nifty LargeMidcap 250 Index, subject to tracking errors.
Edelweiss Nifty Large Midcap 250 Index Fund Regular Plan Payout
14.16% 3Y CAGR
Long Term Capital appreciation. Passive Investment in equity and equity related securities replicating the composition of Nifty LargeMidcap 250 Index, subject to tracking errors.
Bharat Bond Etf Fof April 2032 Regular Plan Growth
7.82% 3Y CAGR
Income over the Target Maturity period. An open ended Target Maturity fund of funds scheme with the primary objective to generate returns by investing in units of BHARAT Bond ETF - April 2032.
Bharat Bond Etf Fof April 2032 Regular Plan Dividend
7.82% 3Y CAGR
Income over the Target Maturity period. An open ended Target Maturity fund of funds scheme with the primary objective to generate returns by investing in units of BHARAT Bond ETF - April 2032.
Edelweiss Crisil Psu Plus Sdl 50 50 Oct 2025 Index Fund Regular Plan Growth
Income over long term. An open-ended Target Maturity Index Fund that seeks to track CRISIL [IBX] 50:50 PSU + SDL Index - October 2025.
Edelweiss Focused Fund Regular Plan Growth
12.96% 3Y CAGR
Long Term Capital appreciation. To generate income by investing in equity and equity related instruments and derivative segment of upto 30 companies